Estrogen and thrombosis: Controversies and common sense

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.

Original languageEnglish (US)
Pages (from-to)77-84
Number of pages8
JournalReviews in Endocrine and Metabolic Disorders
Issue number2
StatePublished - Jun 2011


  • Estrogen
  • Myocardial infraction
  • Stroke
  • Thrombophilia
  • Thrombosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Estrogen and thrombosis: Controversies and common sense'. Together they form a unique fingerprint.

Cite this